메뉴 건너뛰기




Volumn 37, Issue 8, 2013, Pages 559-564

Asenapine (saphrisw®): GC-MS method validation and the postmortem distribution of a new atypical antipsychotic medication

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; ASENAPINE; CLONIDINE; DULOXETINE; FLUOXETINE; GABAPENTIN; ONDANSETRON; PRAMIPEXOLE; PRESCRIPTION DRUG; QUETIAPINE; RISPERIDONE; VALPROIC ACID; ZOLPIDEM; FUSED HETEROCYCLIC RINGS; NEUROLEPTIC AGENT;

EID: 84888879250     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkt076     Document Type: Article
Times cited : (21)

References (5)
  • 1
    • 84888863825 scopus 로고    scopus 로고
    • Saphris,PDR.net.
    • PDR.net. (2012) Saphris. http://www.pdr.net/drugpages/productlabeling.aspx?Mpcode=52402815.
    • (2012)
  • 2
    • 84867714108 scopus 로고    scopus 로고
    • Development and validation of automated SPE-HPLC-MS/ MS methods for the quantification of asenapine, a new antipsychotic agent, and its two major metabolites in human urine
    • De Boer, T., Meulman, E., Meijering, H., Wieling, J., Dogterom, P., Lass, H. (2012) Development and validation of automated SPE-HPLC-MS/ MS methods for the quantification of asenapine, a new antipsychotic agent, and its two major metabolites in human urine. Biomedical Chromatography, 26, 1461-1463.
    • (2012) Biomedical Chromatography , vol.26 , pp. 1461-1463
    • De Boer, T.1    Meulman, E.2    Meijering, H.3    Wieling, J.4    Dogterom, P.5    Lass, H.6
  • 3
    • 84855431162 scopus 로고    scopus 로고
    • Quantification of asenapine and three metabolites in human plasma using liquid chromatography-tandem mass spectrometry with automated solid-phase extraction: application to a phase I clinical trial with asenapine in healthymale subjects
    • De Boer, T., Meulman, E., Meijering, H., Wieling, J., Dogterom, P., Lass, H. (2012) Quantification of asenapine and three metabolites in human plasma using liquid chromatography-tandem mass spectrometry with automated solid-phase extraction: application to a phase I clinical trial with asenapine in healthymale subjects. Biomedical Chromatography, 26, 156-165.
    • (2012) Biomedical Chromatography , vol.26 , pp. 156-165
    • De Boer, T.1    Meulman, E.2    Meijering, H.3    Wieling, J.4    Dogterom, P.5    Lass, H.6
  • 4
    • 84888871043 scopus 로고    scopus 로고
    • Scientific Working Group for Forensic Toxicology (SWGTOX)
    • Doc 003 Revision Draft
    • Scientific Working Group for Forensic Toxicology (SWGTOX). (2012) Standard Practices for Method Validation in Forensic Toxicology. Doc 003 Revision Draft. www.swgtox.org.
    • (2012) Standard Practices for Method Validation in Forensic Toxicology
  • 5
    • 84888867704 scopus 로고    scopus 로고
    • How to quantitatively establish a regression model
    • In California Association of Toxicologists Fall Meeting
    • Pearring, S. (2012) How to quantitatively establish a regression model. In California Association of Toxicologists Fall Meeting
    • (2012)
    • Pearring, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.